Skip to content
  • en
  • ms

  • NADA Profile
    • Corporate Info
      • Message from The Director General of National Anti-Drugs Agency (NADA)
      • Top Management
      • Chief Information Officer (CIO)
      • About NADA
      • History Of NADA
      • Vision, Mission and Objectives
      • Client’s Charter
      • Client Charter Achievement Report
    • Policies, Acts & Circulars
      • State Drug Policy
      • Drugs-Related Act
      • NADA Financial Management Guidelines
      • ICT Management Circulars and Policies
      • Anti-Drug Agency Training Policy (DLAADK)
      • AADK Disciplinary Management Guide
      • Organizational Anti-Corruption Plan (OACP) AADK 2020-2024
      • NADA Anti-Corruption Policy
    • Divisions And Units
      • Treatment, Medicational And Rehabilitation Division
      • Enforcement And Security Division
      • Management Service Division
      • Information Technology And Communication Division
      • Policy, Planning And Research Division
      • Legal Advisory Unit
      • Media And Corporate Communication Unit
      • International Unit
      • Integrity Unit
      • MGDN Secretariat Unit
      • NADA Training Centre
    • Directory
      • Headquarter
      • NADA State Office
      • NADA District Office
      • Rehabilitation Centre
      • NADA Service Centre
      • Community House
      • Client Integration Centre (CIC)
      • Anti-Drugs Border Unit (UAS)
      • NADA Training Centre
  • Services
    • Treatment & Rehabilitation
      • Institution Based Treatment And Rehabilitation
      • Community Based Treatment And Rehabilitation
      • NADA’s Tele Hello
    • Prevention
      • Public Awareness and Anti-Drugs Campaigns
      • High Risk Areas Of Drugs Addiction
      • Drugs Free Family
      • Drug Free Educational Institutions
      • Drugs Free Workplace
      • Drugs Free Community
    • Enforcement
      • Complaints on Drug Problems
      • Hotline Operations Center (PGH)
      • Compliance with the Person Under Surveillance
  • Public
    • General
      • Advertisement/Tender and Quotation Statement
      • Drugs Statistics
      • NADA Research Grant
      • Federal Government Gazette
      • List of Private Drugs Rehabilitation Centers
      • Complaints and Feedback
      • e-Participation Policy
    • Online Services
      • Application for Anti-Drugs SKUAD Membership
      • Application for Anti-Drugs Exhibition
      • e-DrugNews
      • Library of AADK
      • Integrity Complain
      • The Malaysian Anti-Drugs Journal
    • Media & Publishing
      • AADK TV
      • Infographic
      • Informations On Drugs
      • Annual Report
      • Publishing
      • Integrity Lens
      • NADA Scientific Research Study
    • FAQ
      • FAQ : Enforcement And Security
      • FAQ : Pusat Pemulihan Penagihan Narkotik (PUSPEN)
      • FAQ : NADA Service Centre
      • FAQ : Community House
      • FAQ : Client Integration Centre (CIC)
      • FAQ : Private Drug Rehabilitation Centre (PPDP)
      • FAQ : Antidrugs SKUAD
  • NADA Staff
    • Login
      • AADK Official Email
  • en
  • ms

  • NADA Profile
    • Corporate Info
      • Message from The Director General of National Anti-Drugs Agency (NADA)
      • Top Management
      • Chief Information Officer (CIO)
      • About NADA
      • History Of NADA
      • Vision, Mission and Objectives
      • Client’s Charter
      • Client Charter Achievement Report
    • Policies, Acts & Circulars
      • State Drug Policy
      • Drugs-Related Act
      • NADA Financial Management Guidelines
      • ICT Management Circulars and Policies
      • Anti-Drug Agency Training Policy (DLAADK)
      • AADK Disciplinary Management Guide
      • Organizational Anti-Corruption Plan (OACP) AADK 2020-2024
      • NADA Anti-Corruption Policy
    • Divisions And Units
      • Treatment, Medicational And Rehabilitation Division
      • Enforcement And Security Division
      • Management Service Division
      • Information Technology And Communication Division
      • Policy, Planning And Research Division
      • Legal Advisory Unit
      • Media And Corporate Communication Unit
      • International Unit
      • Integrity Unit
      • MGDN Secretariat Unit
      • NADA Training Centre
    • Directory
      • Headquarter
      • NADA State Office
      • NADA District Office
      • Rehabilitation Centre
      • NADA Service Centre
      • Community House
      • Client Integration Centre (CIC)
      • Anti-Drugs Border Unit (UAS)
      • NADA Training Centre
  • Services
    • Treatment & Rehabilitation
      • Institution Based Treatment And Rehabilitation
      • Community Based Treatment And Rehabilitation
      • NADA’s Tele Hello
    • Prevention
      • Public Awareness and Anti-Drugs Campaigns
      • High Risk Areas Of Drugs Addiction
      • Drugs Free Family
      • Drug Free Educational Institutions
      • Drugs Free Workplace
      • Drugs Free Community
    • Enforcement
      • Complaints on Drug Problems
      • Hotline Operations Center (PGH)
      • Compliance with the Person Under Surveillance
  • Public
    • General
      • Advertisement/Tender and Quotation Statement
      • Drugs Statistics
      • NADA Research Grant
      • Federal Government Gazette
      • List of Private Drugs Rehabilitation Centers
      • Complaints and Feedback
      • e-Participation Policy
    • Online Services
      • Application for Anti-Drugs SKUAD Membership
      • Application for Anti-Drugs Exhibition
      • e-DrugNews
      • Library of AADK
      • Integrity Complain
      • The Malaysian Anti-Drugs Journal
    • Media & Publishing
      • AADK TV
      • Infographic
      • Informations On Drugs
      • Annual Report
      • Publishing
      • Integrity Lens
      • NADA Scientific Research Study
    • FAQ
      • FAQ : Enforcement And Security
      • FAQ : Pusat Pemulihan Penagihan Narkotik (PUSPEN)
      • FAQ : NADA Service Centre
      • FAQ : Community House
      • FAQ : Client Integration Centre (CIC)
      • FAQ : Private Drug Rehabilitation Centre (PPDP)
      • FAQ : Antidrugs SKUAD
  • NADA Staff
    • Login
      • AADK Official Email
Agensi Antidadah Kebangsaan > Policies, Acts & Circular > Drugs-Related Act

Drugs-Related Act

akta penagih dadah seksyen 1983

Act 1983 Drugs (Treatment And Rehabilitation)

akta dadah seksyen 234

Dangerous Drugs Act 1952 (Act 234)

Akta 316

Act 316 Dangerous Drugs (Special Preventive Measures) Act 1985

akta 340

Act 340 Dangerous Drugs (Forfeiture Of Property) Act 1988

Akta 638

Act AADK 2004 (Act 638)

POLICIES, ACTS & CIRCULARS
  • Drugs-Related Act
  • NADA Financial Management Guidelines
  • ICT Management Circulars and Policies
  • NADA Anti-Corruption Policy
  • State Drug Policy
  • Drugs-Related Act
  • NADA Financial Management Guidelines
  • ICT Management Circulars and Policies
  • NADA Anti-Corruption Policy
  • State Drug Policy
laman Web QRCode

NATIONAL ANTI-DRUGS AGENCY  MALAYSIA
MINISTRY OF HOME AFFAIRS
Jalan Maktab Perguruan Islam
43000 Kajang, Selangor

Tel : 03 – 8911 2200
Fax : 03 – 8926 2055
E-mail : webmaster[at]adk[dot]gov[dot]my

 AADK Hotline: 1-800-22-2235 / 019 – 626 2233

laman Web QRCode
REFERENCES
  • RSS Feed
  • Sitemap
  • Disclaimer
  • Privacy Policy
  • Security Policy
  • Electronic Archives
  • Credit

Updated :

  • January 10, 2022

Our Visitor

2501689
Total views : 3278236
March 22, 2023

©2021 National Anti-Drugs Agency, All Rights Reserved.
Best viewed using Mozilla Firefox 3, Internet Explorer 11, and Google Chrome with minimum resolution.

X